
What happened?
Shares of life sciences company Revvity (NYSE: RVTY) jumped 12.2% in the morning session after the company reported third-quarter 2026 financial results and raised its full-year guidance.
According to a company press release, Revvity reported third-quarter revenue of $728.9 million, an increase of 10.3% year over year, while GAAP earnings per share from continuing operations reached $0.56. Adjusted earnings per share came in at $1.37, up from $1.18 in the prior-year period. Both top- and bottom-line results beat Wall Street expectations, as consensus estimates projected revenue of $697.9 million and adjusted EPS of $1.30. Revvity also delivered organic revenue growth of 7% year over year.
Revvity raised its full-year guidance, targeting annual revenue of approximately $2.86 billion and adjusted earnings per share of $5.43 at the midpoint. Investors reacted positively to the earnings beat and boosted outlook, which signaled operational momentum and resilient demand.
Is now the time to buy Revvity? Access our full analysis report here, it’s free.
What is the market telling us
Revvity’s shares are quite volatile and have had 15 moves greater than 5% over the last year. But moves this big are rare even for Revvity and indicate this news significantly impacted the market’s perception of the business.
The biggest move we wrote about over the last year was 6 months ago when the stock gained 7.3% on the news that its first-quarter 2026 results surpassed Wall Street's expectations.
The company posted adjusted earnings of $1.06 per share on revenue of $711.1 million, which grew 7% year-on-year. Both figures came in ahead of analysts' consensus estimates. However, the positive quarterly results were tempered by a cautious outlook. Revvity lowered its full-year revenue guidance to a midpoint of $2.83 billion, coming in 5.2% below what analysts had projected.
The company also trimmed its full-year adjusted earnings per share forecast. Despite the weaker-than-expected forecast for the remainder of the year, investors appeared to focus on the first-quarter outperformance, sending the stock higher.
Revvity is up 72.8% since the beginning of the year, and at $169.60 per share, it has set a new 52-week high. Despite the year-to-date gain, investors who bought $1,000 worth of Revvity’s shares 5 years ago would now be looking at only $974.23.
WHILE YOU’RE HERE: The Next Palantir? One satellite company captures images of every point on Earth. Every single day. The Pentagon wants it. Hedge funds are using it to beat earnings. You’ve probably never heard of it.
This is what the early days of Palantir looked like before it became a giant. Same playbook. Different technology. If you missed Palantir, you need to see this. Claim The Stock Ticker for Free HERE.
